Skip to main content

Advertisement

SpringerLink
Log in

Quality of life after intensity-modulated radiation therapy for anal cancer

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Objective

The aim of this study was to evaluate quality of life after intensity-modulated radiation therapy (IMRT) for anal cancer.

Methods

Between 2007 and 2011, 63 patients with anal cancer were treated with IMRT and concurrent chemotherapy, and achieved complete response. These patients completed Functional Assessment of Cancer Therapy-Colorectal (FACT-C) and Medical Outcomes Study Sexual Problems Scale (MOS-SPS) questionnaires during follow-up visits.

Results

Thirty-four patients (54 %) answered at least one questionnaire. Among them, the median radiation dose was 54 Gy to the tumor and 45 Gy to the pelvis. The median interval between treatment and the latest questionnaire was 33 months. On the latest questionnaires, the median total FACT-C score was 111, out of maximum (best possible) score 136. The median scores on the Physical, Social/Family, Emotional Functional, and Colorectal subscales were 24, 24, 19, 21, and 21, out of maximum (best possible) scores 28, 28, 24, 28 and 28, respectively. The median score on the MOS Sexual Problems Scale was 62, out of maximum (worst possible) score 100. Patients with lymph node involvement reported worse total FACT-C scores (p = 0.048), as well as worse Social/Family (p = 0.026) and Emotional (p = 0.032) subscale scores. A history of depression/anxiety was significantly associated with worse Physical (p = 0.034) and Emotional (p = 0.003) subscale scores. The use of vaginal dilator during treatment significantly improved Social/Family subscale scores (p = 0.031).

Conclusion

Overall quality of life scores were acceptable, but sexual functioning scores were suboptimal after IMRT for anal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 102(7):1123–1128

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040–2049

    CAS  PubMed  Google Scholar 

  3. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527–2539

    CAS  PubMed  Google Scholar 

  4. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson 3rd AB, Thomas Jr. CR, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914–1921

    Article  CAS  PubMed  Google Scholar 

  5. Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson 3rd AB, Thomas Jr. CR, Mayer RJ, Haddock MG, Rich TA, Willett CG (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 30(35):4344–4351

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM (1999) Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 80(10):1588–1594

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Vordermark D, Sailer M, Flentje M, Thiede A, Kolbl O (1999) Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 52(3):239–243

    Article  CAS  PubMed  Google Scholar 

  8. Jephcott CR, Paltiel C, Hay J (2004) Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors. Clin Oncol (R Coll Radiol) 16(8):530–535

    Article  CAS  Google Scholar 

  9. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH (2010) Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer 116(4):822–829

    Article  PubMed  Google Scholar 

  10. Provencher S, Oehler C, Lavertu S, Jolicoeur M, Fortin B, Donath D (2010) Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma. Radiat Oncol 5:41–48

    Article  PubMed Central  PubMed  Google Scholar 

  11. Welzel G, Hagele V, Wenz F, Mai SK (2011) Quality of life outcomes in patients with anal cancer after combined radiochemotherapy. Strahlenther Onkol 187(3):175–182

    Article  PubMed  Google Scholar 

  12. Bentzen AG, Balteskard L, Wanderas EH, Frykholm G, Wilsgaard T, Dahl O, Guren MG (2013) Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol 52(4):736–744

    Article  PubMed  Google Scholar 

  13. Brooks CJ, Lee YK, Aitken K, Hansen VN, Tait DM, Hawkins MA (2013) Organ-sparing intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans. Clin Oncol (R Coll Radiol) 25(3):155–161

    Article  CAS  Google Scholar 

  14. Menkarios C, Azria D, Laliberte B, Moscardo CL, Gourgou S, Lemanski C, Dubois JB, Ailleres N, Fenoglietto P (2007) Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2:41–51

    Article  PubMed Central  PubMed  Google Scholar 

  15. Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ (2005) Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63(2):354–361

    Article  PubMed  Google Scholar 

  16. Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY (2005) Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63(1):274–281

    Article  PubMed  Google Scholar 

  17. Kachnic L, Tsai HK, Willins J, Kung JH, Feng JK, Shih HA, Hong TS (2006) 2126: dose-painted intensity modulated radiation therapy for anal cancer: dosimetric comparison and acute toxicity [abstract]. Int J Radiat Oncol Biol Phys 66(Suppl. 3):S280

    Article  Google Scholar 

  18. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ (2007) Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25(29):4581–4586

    Article  CAS  PubMed  Google Scholar 

  19. Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS (2012) Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 82(1):153–158

    Article  PubMed  Google Scholar 

  20. Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT (2011) Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer 117(15):3342–3351

    Article  PubMed  Google Scholar 

  21. Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P (2013) Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol 37(5):461–466

    Article  Google Scholar 

  22. Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86(1):27–33

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Yoo HJ, Kim JC, Eremenco S, Han OS (2005) Quality of life in colorectal cancer patients with colectomy and the validation of the functional assessment of cancer therapy-colorectal (FACT-C), version 4. J Pain Symptom Manag 30(1):24–32

    Article  Google Scholar 

  24. Sherbourne CD (1992) Social functioning: sexual problems measures. In: Stewart AL, Ware JE (eds) Measuring functioning and well-being: the medical outcomes study approach, 1 edn. Duke University Press, Druham, pp. 194–204

    Google Scholar 

  25. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, Chicago

    Google Scholar 

  26. Briere TM, Crane CH, Beddar S, Bhosale P, Mok H, Delclos ME, Krishnan S, Das P (2012) Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients. Radiother Oncol 104(2):161–166

    Article  PubMed  Google Scholar 

  27. Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J (2014) Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. Int J Radiat Oncol Biol Phys 90(3):587–594

    Article  PubMed  Google Scholar 

Download references

Funding

Dr. Tang was supported by a grant from the Ministry of Health of the People’s Republic of China (grant numbers A01113, 136).

Ethical standards

The study was approved by the MD Anderson Institutional Review Board.

Conflict of interest

Yu Tang, Christopher Crane, Cathy Eng, Bruce Minsky, Marc Delclos, Sunil Krishnan, Daniel Malatek, Morris Gould, and Prajnan Das declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Panjiayuannanli 17#, Beijing, Chaoyang District, 100021, China

    Yu Tang

  2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX, 77030, USA

    Christopher H. Crane, Bruce D. Minsky, Marc E. Delclos, Sunil Krishnan, Daniel Malatek, Morris S. Gould & Prajnan Das

  3. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    Cathy Eng

Authors
  1. Yu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher H. Crane
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cathy Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruce D. Minsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marc E. Delclos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sunil Krishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniel Malatek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Morris S. Gould
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Prajnan Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prajnan Das.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, Y., Crane, C.H., Eng, C. et al. Quality of life after intensity-modulated radiation therapy for anal cancer. J Radiat Oncol 4, 291–298 (2015). https://doi.org/10.1007/s13566-015-0209-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-015-0209-4

Keywords

Search

Navigation